Eisai Co., Ltd. (Japanese: エーザイ株式会社, Hepburn: Ēzai Kabushiki-gaisha) is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10...

Zonegran, before Élan transferred their interests in zonisamide to Eisai Co., Ltd. in 2004. Eisai also markets Zonegran in Asia (China, Taiwan, and fourteen others)...

kinds of thyroid cancer and for other cancers as well. It was developed by Eisai Co. and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and...

2024. Retrieved 19 February 2024. "Eisai Announces Japan Launch Of Anticancer Agent Halaven" (Press release). Eisai Co., Ltd. 19 July 2011. Retrieved 15...

under the brand name Fycompa, is an anti-epileptic medication developed by Eisai Co. that is used in addition to other drugs to treat partial seizures and...

Akynzeo (netupitant/palonosetron), for nausea and vomiting, licensed by Eisai Co. and Helsinn Therapeutics. Alecensa (alectinib), for ALK-positive non-small...

Chugai Pharmaceutical Co., Ltd. (TYO: 4519) Daiichi Sankyo Company, Limited (TYO: 4568) Eisai Co., Ltd. (TYO: 4523) Kyowa Hakko Kirin Co., Ltd. (TYO: 4151)...

"EISAI TO LAUNCH IN-HOUSE DEVELOPED NEW ANTI-INSOMNIA DRUG DAYVIGO® (LEMBOREXANT) WITH INDICATION FOR INSOMNIA IN JAPAN | News Release：2020 | Eisai Co...

2017, Arena announced that it is selling Belviq to its Japanese partner, Eisai Co. Ltd., which will manufacture and market the drug; Arena will draw a royalty...

fexofenadine Antihistamines Allergic rhinitis, Urticaria 6–11 years Aricept ODT Eisai Co. yes donepezil Acetylcholinesterase inhibitors Alzheimer's disease adults...